Neosem네오셈
253590 · KOSDAQ · ₩253590 · 네오셈
₩18,780▲ ₩1,650 (9.63%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩64B | ₩105B | ₩101B | ₩75B | ₩37B |
| Cost of sales | ₩34B | ₩66B | ₩70B | ₩47B | ₩17B |
| Gross profit | ₩30B | ₩39B | ₩31B | ₩28B | ₩20B |
| Operating income | ₩4.1B | ₩16B | ₩8.1B | ₩8.4B | ₩4.8B |
| Net income | ₩5.3B | ₩19B | ₩8.3B | ₩10B | ₩5.6B |
| Net income to shareholders | ₩5.3B | ₩19B | ₩8.3B | ₩10B | ₩5.6B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩155B | ₩142B | ₩106B | ₩131B | ₩89B |
| Current assets | ₩97B | ₩99B | ₩71B | ₩100B | ₩60B |
| Cash and equivalents | ₩20B | ₩52B | ₩30B | ₩30B | ₩24B |
| Total liabilities | ₩36B | ₩26B | ₩20B | ₩69B | ₩38B |
| Current liabilities | ₩15B | ₩22B | ₩17B | ₩65B | ₩9.9B |
| Borrowings | ₩23B | ₩2.6B | ₩4.4B | ₩22B | ₩29B |
| Total equity | ₩119B | ₩116B | ₩87B | ₩62B | ₩51B |
| Shareholders' equity | ₩119B | ₩116B | ₩87B | ₩62B | ₩51B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩3.7B | ₩19B | ₩11B | ₩13B | −₩4.6B |
| Capital spending | ₩16B | ₩4.2B | ₩5.5B | ₩3.2B | ₩2.6B |
| Free cash flow | −₩12B | ₩15B | ₩5B | ₩10B | −₩7.1B |
| Dividends paid | ₩2.5B | ₩1.2B | ₩1.3B | ₩545M | ₩725M |
Consolidated where available. Amounts in won.
Also known as: Neosem / 네오셈 / 253590 / KRX:253590
Source: KRX statistical information